Source BioScience Completes Acquisition of Select Pharma Laboratories

August 17, 2015
Pharmaceutical Technology Editors
PTSM: Pharmaceutical Technology Sourcing and Management
Volume 11, Issue 9

With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical testing services.

Source BioScience announced that it has completed its acquisition of Select Pharma Laboratories, a provider of stability storage and testing services to the pharmaceutical, animal health, and medical devices sectors.

Based in Stirling, Scotland, Select’s portfolio of laboratory services includes chemistry, physical, and microbiological analyses for application in therapeutics batch release and product release to the EU market. Select operates from GMP-accredited facilities, and holds accreditations with the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA).

With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical testing services.

Nick Ash, CEO of Source BioScience said in a press statement, “The acquisition of Select will provide the company with the expertise and capability to provide stability testing services that are highly complementary to the group’s existing stability storage services. Significant cross-selling opportunities are apparent with our existing customer base, enabling them to reduce the number of service providers and de-risk the process by avoiding unnecessary sample transfers.”

Source: Source BioScience